Log in

EVERESTO Everest Organics Ltd. BSE · India

Everest Organics (EVERESTO) news

Everest Organics Ltd. is a public biotech or pharmaceutical company listed on BSE under the ticker EVERESTO, recorded under India. The directory classifies it as Drug manufacturing / APIs. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Everest Organics news

We have not published a story on Everest Organics yet. When there is news, it will appear here.

Questions about Everest Organics

What is the ticker symbol of Everest Organics?

Everest Organics Ltd. trades under the ticker EVERESTO on BSE.

Where is Everest Organics listed?

Everest Organics Ltd. is listed on BSE.

Which country or territory is Everest Organics listed under?

Our directory records Everest Organics Ltd. under India.

What does Everest Organics do?

Our directory classifies Everest Organics Ltd. as: Drug manufacturing / APIs. This is a directory classification, not a description of the pipeline.

What is the ISIN of Everest Organics?

The ISIN recorded for Everest Organics Ltd. is INE334C01029.

Does aibio.space cover Everest Organics?

aibio.space lists Everest Organics Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Everest Organics?

Companies in our directory listed in the same country and business area as Everest Organics: Asston Pharmaceuticals, Par Drugs and Chemicals, Astal Laboratories, IOL Chemicals & Pharmaceuticals, Concord Biotech, Mercury Laboratories.

Investor discussion: Everest Organics

Members talk about Everest Organics (EVERESTO). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open BSE:EVERESTO on TradingView.

Listing details

Everest Organics Ltd. is a public biotech or pharmaceutical company listed on BSE under the ticker EVERESTO, recorded under India. The directory classifies it as Drug manufacturing / APIs. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Everest Organics Ltd.
Ticker
EVERESTO
Listing
BSE
Country or territory
India
Business scope
Drug manufacturing / APIs
ISIN
INE334C01029
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.